Review Article
Hepatitis C Virus: A Critical Appraisal of New Approaches to Therapy
Table 6
RGT Guidelines: Treatment-Naïve Patients.
| When to Evaluate HCV-RNA Results |
| | Boceprevir [6] | |
| At Treatment Week 8 and Week 12 | At Treatment Week 24 | Recommendation |
| Undetectable | Undetectable | Complete three-medicine regimen at TW28 | Detectable | Undetectable | Continue all three medicines and finish through TW36; and then Administer peginterferon alfa and ribavirin and finish through TW48 |
| | Telaprevir [5] | |
| At Treatment Week 4 and Week 12 |
Recommendation |
| Undetectable |
Receive an additional 12 weeks of PEG-IFN/RBV alone for total treatment duration of 24 weeks | Detectable |
Receive an additional 36 weeks of PEG-IFN/RBV alone for a total treatment duration of 48 weeks |
|
|
TW: treatment week.
|